Rezaei S - Search Results

1

Decoy oligodeoxynucleotides: A promising therapeutic strategy for inflammatory skin disorders.

Mahjoubin-Tehran M, Rezaei S, Karav S, Kesharwani P, Sahebkar A. Mahjoubin-Tehran M, et al. Among authors: rezaei s. Hum Immunol. 2024 Nov;85(6):111161. doi: 10.1016/j.humimm.2024.111161. Epub 2024 Oct 24. Hum Immunol. 2024. PMID: 39454315 Review.

2

Decoys as potential therapeutic tools for diabetes.

Mahjoubin-Tehran M, Rezaei S, Atkin SL, Montecucco F, Sahebkar A. Mahjoubin-Tehran M, et al. Among authors: rezaei s. Drug Discov Today. 2021 Jul;26(7):1669-1679. doi: 10.1016/j.drudis.2021.04.004. Epub 2021 Apr 20. Drug Discov Today. 2021. PMID: 33862194 Review.

3

Therapeutic Potential of Decoys for Prostate Cancers: A Review of Recent Updates.

Rezaei S, Mahjoubin-Tehran M, Iratni R, Sahebkar A. Rezaei S, et al. Curr Med Chem. 2024;31(25):3954-3965. doi: 10.2174/0929867330666230505154319. Curr Med Chem. 2024. PMID: 37151059 Review.

4

Nanospheres for curcumin delivery as a precision nanomedicine in cancer therapy.

Mahjoubin-Tehran M, Rezaei S, Kesharwani P, Sahebkar A. Mahjoubin-Tehran M, et al. Among authors: rezaei s. J Biomater Sci Polym Ed. 2024 Oct;35(14):2250-2274. doi: 10.1080/09205063.2024.2371186. Epub 2024 Jul 3. J Biomater Sci Polym Ed. 2024. PMID: 38958210 Review.

5

Androgen receptor-related micro RNAs in prostate cancer and their role in antiandrogen drug resistance.

Rezaei S, Mahjoubin Tehran M, Sahebkar A, Jalili A, Aghaee-Bakhtiari SH. Rezaei S, et al. J Cell Physiol. 2020 Apr;235(4):3222-3234. doi: 10.1002/jcp.29275. Epub 2019 Oct 10. J Cell Physiol. 2020. PMID: 31599460 Review.

6

Decoy oligodeoxynucleotide technology: an emerging paradigm for breast cancer treatment.

Tehran MM, Rezaei S, Jalili A, Aghaee-Bakhtiari SH, Sahebkar A. Tehran MM, et al. Among authors: rezaei s. Drug Discov Today. 2020 Jan;25(1):195-200. doi: 10.1016/j.drudis.2019.10.008. Epub 2019 Oct 25. Drug Discov Today. 2020. PMID: 31669652 Review.

7

Peptide decoys: a new technology offering therapeutic opportunities for breast cancer.

Mahjoubin-Tehran M, Rezaei S, Jalili A, Aghaee-Bakhtiari SH, Orafai HM, Jamialahmadi T, Sahebkar A. Mahjoubin-Tehran M, et al. Among authors: rezaei s. Drug Discov Today. 2020 Mar;25(3):593-598. doi: 10.1016/j.drudis.2020.01.010. Epub 2020 Jan 21. Drug Discov Today. 2020. PMID: 31978387 Review.

8

A comprehensive review of online resources for microRNA-diseases associations: the state of the art.

Mahjoubin-Tehran M, Rezaei S, Jalili A, Sahebkar A, Aghaee-Bakhtiari SH. Mahjoubin-Tehran M, et al. Among authors: rezaei s. Brief Bioinform. 2022 Jan 17;23(1):bbab381. doi: 10.1093/bib/bbab381. Brief Bioinform. 2022. PMID: 34571538 Review.

9

Harnessing the Therapeutic Potential of Antimicrobial Peptides for Cancers: State of the Art.

Mahjoubin-Tehran M, Rezaei S, Aghaee-Bakhtiari SH, Sahebkar A, Oskuee RK, Mahmoudi A, Jalili A. Mahjoubin-Tehran M, et al. Among authors: rezaei s. Curr Top Med Chem. 2023;23(16):1542-1558. doi: 10.2174/1568026623666230328161236. Curr Top Med Chem. 2023. PMID: 36994977 Review.

10

Targeting PCSK9 as a key player in lipid metabolism: exploiting the therapeutic and biosensing potential of aptamers.

Mahjoubin-Tehran M, Rezaei S, Santos RD, Jamialahmadi T, Almahmeed W, Sahebkar A. Mahjoubin-Tehran M, et al. Among authors: rezaei s. Lipids Health Dis. 2024 May 25;23(1):156. doi: 10.1186/s12944-024-02151-8. Lipids Health Dis. 2024. PMID: 38796450 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters